These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 16502117

  • 1. Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia.
    Su DH, Liao KM, Chang YC, Tsai KS.
    J Bone Miner Metab; 2006; 24(2):114-7. PubMed ID: 16502117
    [Abstract] [Full Text] [Related]

  • 2. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
    Sato K, Obara T, Yamazaki K, Kanbe M, Nakajima K, Yamada A, Yanagisawa T, Kato Y, Nishikawa T, Takano K.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ, Kwon SH, Kim SW, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2003 Nov; 60(3):127-33. PubMed ID: 12931040
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.
    Firth RG, Grant CS, Riggs BL.
    Am J Med; 1985 Apr; 78(4):669-73. PubMed ID: 2984933
    [Abstract] [Full Text] [Related]

  • 6. [Sporadic adult hypophosphatemic vitamin D resistant osteomalacia (phosphate diabetes) and hyperparathyroidism].
    Kistler HJ, Bonetti A, Frey P, Fischer JA.
    Schweiz Med Wochenschr; 1976 Dec 18; 106(51):1855-62. PubMed ID: 1013714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature].
    Moreira RO, Leal CT, Lacativa PG, Figueiredo JG, Lima MB, Farias ML.
    Arq Bras Endocrinol Metabol; 2006 Feb 18; 50(1):150-5. PubMed ID: 16628288
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia.
    Bhadada SK, Palnitkar S, Qiu S, Parikh N, Talpos GB, Rao SD.
    J Clin Endocrinol Metab; 2013 Nov 18; 98(11):4273-8. PubMed ID: 23956343
    [Abstract] [Full Text] [Related]

  • 12. [Secondary hyperparathyroidism].
    Diaconescu MR, Costea I, Terinte R, Diaconescu S, Covic M, Zbranca E.
    Chirurgia (Bucur); 1995 Nov 18; 44(1):27-34. PubMed ID: 7496211
    [Abstract] [Full Text] [Related]

  • 13. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
    Younis E, Jarrah N, Sroujieh AS, Al Hadidy A, Ajlouni K.
    Endocr Pract; 2001 Nov 18; 7(5):375-8. PubMed ID: 11585374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP.
    G Chir; 2006 Nov 18; 27(1-2):9-13. PubMed ID: 16608626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sonography for early diagnosis of enlarged parathyroid glands in patients with secondary hyperparathyroidism.
    Takebayashi S, Matsui K, Onohara Y, Hidai H.
    AJR Am J Roentgenol; 1987 May 18; 148(5):911-4. PubMed ID: 3554924
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 18; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.